Steven Almo is the Chair of the Department of Biochemistry at the Albert Einstein College of Medicine, where he is Professor of Biochemistry and co-leader of the Cancer Therapeutics Program for the Montefiore Einstein Comprehensive Cancer Center. Dr. Almo holds the Wollowick Family Foundation Chair in Immunology and is Director of Einstein’s Macromolecular Therapeutics Development Facility, a resource dedicated to the development and optimization of protein-based therapeutics. Dr. Almo is recognized for his broad contributions to structural biology, immune regulatory mechanisms and technology development. After obtaining his Bachelor of Science in biology from the Massachusetts Institute of Technology, Dr. Almo earned his Doctor of Philosophy in biophysics from Harvard University. He then completed postdoctoral training in cell biology and biophysics at Johns Hopkins University School of Medicine. His high-resolution structural and functional analyses of the mammalian immune system have resulted in the unprecedented understanding of the molecular mechanisms that control immunity and are guiding the development of novel antigen-selective strategies for the treatment of infectious diseases, autoimmune diseases and cancers.